The drug is a novel gene therapy to treat knee OA. Kolon developed it at a cost of more than 200 billion won ($143 million) since 1999. After clinical trials in Korea and the United States, the drug ...

Amcor plc AMCR has entered into an agreement with Kolon Industries to co-develop and commercialize more sustainable polyester ...

Anchor] Do you remember the so-called 'Invossa incident' that caused a stir in society five years ago?It was released as the ...

Even if Kolon Group Chairman Lee Woong-yeol and others were acquitted in the first trial, the victims of the Invossa incident ...

Amcor (NYSE: AMCR, ASX: AMC), a global leader in responsible packaging solutions, has signed a strategic collaboration ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Der Gemeinsame Bundesausschuss hat Mindestmengen für die Kolon- und Rektumkarzinom-Chirurgie beschlossen. Über die Hälfte der ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...